Page last updated: 2024-08-23

oltipraz and Lymphoma, T-Cell, Cutaneous

oltipraz has been researched along with Lymphoma, T-Cell, Cutaneous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baron, P; Polsky, B; Prochaska, HJ; Yeh, Y	1

Other Studies

1 other study(ies) available for oltipraz and Lymphoma, T-Cell, Cutaneous

Article	Year
Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication. Proceedings of the National Academy of Sciences of the United States of America, 1993, May-01, Volume: 90, Issue:9 Topics: Antiviral Agents; Dose-Response Relationship, Drug; Glutathione; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphoma, T-Cell, Cutaneous; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Pyrazines; Reverse Transcriptase Inhibitors; Skin Neoplasms; Thiones; Thiophenes; Time Factors; Tumor Cells, Cultured; Virus Replication; Zidovudine	1993

Article

Year

Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

Proceedings of the National Academy of Sciences of the United States of America, 1993, May-01, Volume: 90, Issue:9

Topics: Antiviral Agents; Dose-Response Relationship, Drug; Glutathione; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphoma, T-Cell, Cutaneous; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Pyrazines; Reverse Transcriptase Inhibitors; Skin Neoplasms; Thiones; Thiophenes; Time Factors; Tumor Cells, Cultured; Virus Replication; Zidovudine

1993